Novo Nordisk (NVO) Stocktwits Mentions Statistics 2025

424 11%

1W 6.4% 1M 20.5% 3M 89.3%

Est. daily mentions on Stocktwits.

Similar companies

Company		Stocktwits Mentions
	Johnson & Johnson JNJ	259 27%
	Eli Lilly and Company LLY	260 16.6%
	Pfizer PFE	763 0.5%
	Astrazeneca AZN	115 0.9%
	AbbVie ABBV	79 1.3%

Month over Month

Est. daily mentions on Stocktwits.

Sep 2025	633	55.4%
Aug 2025	1,418	362.5%
Jul 2025	307	13.9%
Jun 2025	356	17.7%
May 2025	303

How often is Novo Nordisk mentioned on StockTwits?

Novo Nordisk was mentioned an estimated 424 times in discussions on StockTwits yesterday.

Analyzing Stocktwits Mentions, how is Novo Nordisk performing compared to its industry peers?

Compared to its peers, Novo Nordisk ranks in the 56th percentile when it comes to Stocktwits Mentions.

What does a high frequency of StockTwits mentions indicate for Novo Nordisk's market sentiment?

A high frequency of mentions on StockTwits for Novo Nordisk could indicate strong market interest or sentiment towards the company. It often reflects the trading community's engagement with Novo Nordisk's stock, potentially signaling bullish or bearish trends based on the context of the discussions.

How often does AltIndex update information on Novo Nordisk's mentions on StockTwits?

AltIndex updates the data on Novo Nordisk's mentions on StockTwits daily. This frequent update schedule ensures that investors have access to the most current insights into market sentiment and discussion dynamics related to Novo Nordisk's on the platform.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.